MedTrace Logo

Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD

NCT03158558 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2018-12-19

No results posted yet for this study

Summary

The purpose of this study is to test an intensive, multi-couple group version of a couple therapy for PTSD delivered to active duty Service Members or Veterans with PTSD and their romantic partners in a single weekend retreat. The study will be conducted on or near Fort Hood in Kileen, Texas. Twenty-four couples will be treated with this therapy and assessed immediately before treatment, 1 month after treatment, and 3 months after treatment.

Conditions

Interventions

BEHAVIORAL

Accelerated, Multi-Couple Group CBCT for PTSD

Intensive weekend retreat version of cognitive-behavioral conjoint therapy for PTSD (Monson \& Fredman, 2012)

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • US Department of Veterans Affairs

    collaborator FED

  • The University of Texas Health Science Center at San Antonio

    collaborator OTHER

  • The Citadel

    collaborator UNKNOWN

  • Toronto Metropolitan University

    collaborator OTHER

  • University of Denver

    collaborator OTHER

  • Duke University

    collaborator OTHER

  • VA Boston Healthcare System

    collaborator FED

  • Penn State University

    lead OTHER

Principal Investigators

  • Steffany J. Fredman, Ph.D. · The Pennsylvania State University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03158558 on ClinicalTrials.gov